Celldemic

· Seqirus Netherlands B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Celldemic, covering 2025-01-29 to 2025-01-29. Get the full timeline:

Most recent: EMA Authorised: Celldemic (Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen) — Seqirus Netherlands B.V.